References
- Brody H. Human papillomavirus. Nature. 2012;488(7413):S1.
doi:10.1038/488S1a
- Harden ME, Munger K. Human papillomavirus molecular biology. Mutat Res
Rev Mutat Res. 2017;772:3-12. doi: 10.1016/j.mrrev.2016.07.002
- de Sanjosé S, Brotons M, Pavón MA. The natural history of human
papillomavirus infection. Best Pract Res Clin Obstet Gynaecol.
2018;47:2-13. doi: 10.1016/j.bpobgyn.2017.08.015
- Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of
HPV-related disease. Best Pract Res Clin Obstet Gynaecol.
2018;47:14-26. doi:10.1016/j.bpobgyn.2017.08.006
- Della Fera AN, Warburton A, Coursey TL, Khurana S, McBride AA.
Persistent Human Papillomavirus Infection. Viruses. 2021;13(2):321.
doi:10.3390/v13020321
- Taylor MM, Wi T, Gerbase A, Thwin SS, Gottlieb S, Babovic MT, et al.
Assessment of country implementation of the WHO global health sector
strategy on sexually transmitted infections (2016-2021). PLoS One.
2022;17(5):e0263550. doi: 10.1371/journal.pone.0263550
- Nguyen HP, Ramírez-Fort MK, Rady PL. The biology of human
papillomaviruses. Curr Probl Dermatol. 2014;45:19-32. doi:
10.1159/000355959
- Araldi RP, Sant’Ana TA, Módolo DG, de Melo TC, Spadacci-Morena DD, de
Cassia Stocco R, Cerutti JM, de Souza EB. The human papillomavirus
(HPV)-related cancer biology: An overview. Biomed Pharmacother.
2018;106:1537-1556. doi:10.1016/j.biopha.2018.06.149.
- Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human
papillomavirus molecular biology and disease association. Rev Med
Virol. 2015;25 Suppl 1(Suppl Suppl 1):2-23. doi: 10.1002/rmv.1822.
- Cerqueira C, Schiller JT. Papillomavirus assembly: An overview and
perspectives. Virus Res. 2017;231:103-107. doi:
10.1016/j.virusres.2016.11.010
- McBride AA. Human papillomaviruses: diversity, infection and host
interactions. Nat Rev Microbiol. 2022;20(2):95-108. doi:
10.1038/s41579-021-00617-5
- Wakabayashi R, Nakahama Y, Nguyen V, Espinoza JL. The Host-Microbe
Interplay in Human Papillomavirus-Induced Carcinogenesis.
Microorganisms. 2019;7(7):199. doi: 10.3390/microorganisms7070199
- de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of
câncer attributable to HPV by site, country and HPV type. Int J
Cancer. 2017;141(4):664-670. doi: 10.1002/ijc.30716
- de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE,
Lloveras B, et al. Human papillomavirus genotype attribution in
invasive cervical cancer: a retrospective cross-sectional worldwide
study. Lancet Oncol. 2010;11(11):1048-56. doi:
10.1016/S1470-2045(10)70230-8
- Oh JK, Weiderpass E. Infection and cancer: global distribution and
burden of diseases. Ann Glob Health. 2014;80(5):384-92. doi:
10.1016/j.aogh.2014.09.013
- Manini I, Montomoli E. Epidemiology and prevention of Human
Papillomavirus. Ann Ig. 2018;30(4 Supple 1):28-32. doi:
10.7416/ai.2018.2231
- Bogale AL, Belay NB, Medhin G, Ali JH. Molecular epidemiology of human
papillomavirus among HIV infected women in developing countries:
systematic review and meta-analysis. Virol J. 2020;17(1):179. doi:
10.1186/s12985-020-01448-1
- Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev.
2003;16(1):1-17. doi:10.1128/CMR.16.1.1-17.2003
- Florin L, Sapp M, Spoden GA. Host-cell factors involved in
papillomavirus entry. Med Microbiol Immunol. 2012;201(4):437-48. doi:
10.1007/s00430-012-0270-1
- Day PM, Schelhaas M. Concepts of papillomavirus entry into host cells.
Curr Opin Virol. 2014;4:24-31. doi: 10.1016/j.coviro.2013.11.002
- Vashisht S, Mishra H, Mishra PK, Ekielski A, Talegaonkar S. Structure,
Genome, Infection Cycle and Clinical Manifestations Associated with
Human Papillomavirus. Curr Pharm Biotechnol. 2019;20(15):1260-1280.
doi: 10.2174/1389201020666190802115722
- Stanley M. Host defence and persistent human papillomavirus infection.
Curr Opin Virol. 2021;51:106-110. doi: 10.1016/j.coviro.2021.09.010
- Frazer IH. Prevention of cervical cancer through papillomavirus
vaccination. Nat Rev Immunol. 2004;4(1):46-54. doi: 10.1038/nri1260
- Roden RBS, Stern PL. Opportunities and challenges for human
papillomavirus vaccination in cancer. Nat Rev Cancer.
2018;18(4):240-254. doi: 10.1038/nrc.2018.13
- Wang R, Pan W, Jin L, Huang W, Li Y, Wu D, et al. Human papillomavirus
vaccine against cervical cancer: Opportunity and challenge. Cancer
Lett. 2020;471:88-102. doi: 10.1016/j.canlet.2019.11.039
- Rosalik K, Tarney C, Han J. Human Papilloma Virus Vaccination.
Viruses. 2021;13(6):1091. doi: 10.3390/v13061091
- Petrie K, Wells A, Eckert LO. Human Papillomavirus Vaccine: The Cancer
Prevention Moonshot. Obstet Gynecol Clin North Am. 2023;50(2):339-348.
doi: 10.1016/j.ogc.2023.02.006
- Quinlan JD. Human Papillomavirus: Screening, Testing, and Prevention.
Am Fam Physician. 2021;104(2):152-159.
- Kombe Kombe AJ, Li B, Zahid A, Mengist HM, Bounda GA, Zhou Y, Jin T.
Epidemiology and Burden of Human Papillomavirus and Related Diseases,
Molecular Pathogenesis, and Vaccine Evaluation. Front Public Health.
2021;8:552028. doi: 10.3389/fpubh.2020.552028
- Chelimo C, Wouldes TA, Cameron LD, Elwood JM. Risk factors for and
prevention of human papillomaviruses (HPV), genital warts and cervical
cancer. J Infect. 2013;66(3):207-17. doi: 10.1016/j.jinf.2012.10.024
- Cheng L, Wang Y, Du J. Human Papillomavirus Vaccines: An Updated
Review. Vaccines (Basel). 2020;8(3):391. doi: 10.3390/vaccines8030391
- Garbuglia AR, Lapa D, Sias C, Capobianchi MR, Del Porto P. The Use of
Both Therapeutic and Prophylactic Vaccines in the Therapy of
Papillomavirus Disease. Front Immunol. 2020;11:188. doi:
10.3389/fimmu.2020.00188
- Kamolratanakul S, Pitisuttithum P. Human Papillomavirus Vaccine
Efficacy and Effectiveness against Cancer. Vaccines (Basel).
2021;9(12):1413. doi: 10.3390/vaccines9121413
- Suresh A, Suresh P, Biswas R, Rajanbabu A, Sreedhar S, Biswas L.
Prevalence of high-risk HPV and its genotypes-Implications in the
choice of prophylactic HPV vaccine. J Med Virol. 2021;93(8):5188-5192.
doi: 10.1002/jmv.27015
- Yousefi Z, Aria H, Ghaedrahmati F, Bakhtiari T, Azizi M, Bastan R, et
al. An Update on Human Papilloma Virus Vaccines: History, Types,
Protection, and Efficacy. Front Immunol. 2022;12:805695. doi:
10.3389/fimmu.2021.805695
- Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J,
Bruni L, et al. Global burden of human papillomavirus and related
diseases. Vaccine. 2012;30 Suppl 5:F12-23. doi:
10.1016/j.vaccine.2012.07.055
- Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S.
Cervical human papillomavirus prevalence in 5 continents:
meta-analysis of 1 million women with normal cytological findings. J
Infect Dis. 2010;202(12):1789-99. doi: 10.1086/657321
- de Sanjosé S, Diaz M, Castellsagué X, Clifford G, Bruni L, Muñoz N,
Bosch FX. Worldwide prevalence and genotype distribution of cervical
human papillomavirus DNA in women with normal cytology: a
meta-analysis. Lancet Infect Dis. 2007;7(7):453-9. doi:
10.1016/S1473-3099(07)70158-5
- Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, et al.
Mechanistic role of HPV-associated early proteins in cervical cancer:
Molecular pathways and targeted therapeutic strategies. Crit Rev Oncol
Hematol. 2022;174:103675. doi: 10.1016/j.critrevonc.2022.103675
- Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley
MA. The biology and life-cycle of human papillomaviruses. Vaccine.
2012;30 Suppl 5:F55-70. doi: 10.1016/j.vaccine.2012.06.083
- Oyervides-Muñoz MA, Pérez-Maya AA, Rodríguez-Gutiérrez HF,
Gómez-Macias GS, Fajardo-Ramírez OR, Treviño V, et al. Understanding
the HPV integration and its progression to cervical cancer. Infect
Genet Evol. 2018;61:134-144. doi: 10.1016/j.meegid.2018.03.003
- McBride AA, Warburton A, Khurana S. Multiple Roles of Brd4 in the
Infectious Cycle of Human Papillomaviruses. Front Mol Biosci.
2021;8:725794. doi: 10.3389/fmolb.2021.725794
- Aksoy P, Gottschalk EY, Meneses PI. HPV entry into cells. Mutat Res
Rev Mutat Res. 2017;772:13-22. doi:
- Doorbar J. Host control of human papillomavirus infection and disease.
Best Pract Res Clin Obstet Gynaecol. 2018;47:27-41. doi:
10.1016/j.bpobgyn.2017.08.001
- Castellsagué X. Natural history and epidemiology of HPV infection and
cervical cancer. Gynecol Oncol. 2008;110(3 Suppl 2):S4-7. doi:
10.1016/j.ygyno.2008.07.045
- Mirghani H, Sturgis EM, Aupérin A, Monsonego J, Blanchard P. Is there
an increased risk of cancer among spouses of patients with an
HPV-related cancer: A systematic review. Oral Oncol. 2017;67:138-145.
doi: 10.1016/j.oraloncology.2017.02.024
- Hemmat N, Bannazadeh Baghi H. Association of human papillomavirus
infection and inflammation in cervical cancer. Pathog Dis.
2019;77(5):ftz048. doi: 10.1093/femspd/ftz048
- Vashisht S, Mishra H, Mishra PK, Ekielski A, Talegaonkar S. Structure,
Genome, Infection Cycle and Clinical Manifestations Associated with
Human Papillomavirus. Curr Pharm Biotechnol. 2019;20(15):1260-1280.
doi: 10.2174/1389201020666190802115722
- Li S, Ye M, Chen Y, Gong Q, Mei B. Genetic variation of E6 and E7
genes of human papillomavirus 52 from Central China. J Med Virol.
2021;93(6):3849-3856. doi: 10.1002/jmv.26690
- Duvlis S, Dabeski D, Hiljadnikova-Bajro M, Osmani D, Memeti S. HPV
E6/E7mRNA association with interleukin 10 (rs1800872) polymorphism in
a group of Macedonian women. J Med Virol. 2022;94(9):4485-4489. doi:
10.1002/jmv.27858
- Ye M, Li S, Luo P, Tang X, Gong Q, Mei B. Genetic variation of E6, E7,
and L1 genes of human papillomavirus 51 from central China. J Med
Virol. 2022;94(6):2811-2823. doi: 10.1002/jmv.27603
- Castle PE, Maza M. Prophylactic HPV vaccination: past, present, and
future. Epidemiol Infect. 2016;144(3):449-68. doi:
10.1017/S0950268815002198. Epub 2015 Oct 2. Erratum in: Epidemiol
Infect. 2016 Aug;144(11):2472.
- Dai Z, Si M, Su X, Wang W, Zhang X, Gu X, et al. Willingness to human
papillomavirus (HPV) vaccination and influencing factors among male
and female university students in China. J Med Virol. 2022
Jun;94(6):2776-2786. doi: 10.1002/jmv.27478
- Huang R, Gan R, Zhang D, Xiao J. The comparative safety of human
papillomavirus vaccines: A Bayesian network meta-analysis. J Med
Virol. 2022;94(2):729-736. doi: 10.1002/jmv.27304
- Araldi RP, Assaf SMR, Carvalho RF, Carvalho MACR, Souza JM, Magnelli
RF, et al. Papillomaviruses: a systematic review. Genet Mol Biol.
2017;40(1):1-21. doi: 10.1590/1678-4685-GMB-2016-0128
- Magalhães GM, Vieira ÉC, Garcia LC, De Carvalho-Leite MLR, Guedes ACM,
Araújo MG. Update on human papilloma virus - part I: epidemiology,
pathogenesis, and clinical spectrum. An Bras Dermatol.
2021;96(1):1-16. doi: 10.1016/j.abd.2020.11.003
- Malik S, Sah R, Muhammad K, Waheed Y. Tracking HPV Infection,
Associated Cancer Development, and Recent Treatment Efforts-A
Comprehensive Review. Vaccines (Basel). 2023;11(1):102. doi:
10.3390/vaccines11010102
- Mitra T, Elangovan S. Cervical cancer development, chemoresistance,
and therapy: a snapshot of involvement of microRNA. Mol Cell Biochem.
2021;476(12):4363-4385. doi: 10.1007/s11010-021-04249-4
- Shanmugasundaram S, You J. Targeting Persistent Human Papillomavirus
Infection. Viruses. 2017;9(8):229. doi: 10.3390/v9080229
- Gupta S, Kumar P, Das BC. HPV: Molecular pathways and targets. Curr
Probl Cancer. 2018;42(2):161-174. doi:
10.1016/j.currproblcancer.2018.03.003
- Gupta AK, Kumar M. HPVomics: An integrated resource for the human
papillomavirus epitome and therapeutics. Genomics.
2020;112(6):4853-4862. doi: 10.1016/j.ygeno.2020.08.025
- Zhen S, Qiang R, Lu J, Tuo X, Yang X, Li X. CRISPR/Cas9-HPV-liposome
enhances antitumor immunity and treatment of HPV infection-associated
cervical cancer. J Med Virol. 2023;95(1):e28144. doi:
10.1002/jmv.28144
- Dong Z, Hu R, Du Y, Tan L, Li L, Du J, et al. Immunodiagnosis and
Immunotherapeutics Based on Human Papillomavirus for HPV-Induced
Cancers. Front Immunol. 2021;11:586796. doi: 10.3389/fimmu.2020.586796
- Shamseddine AA, Burman B, Lee NY, Zamarin D, Riaz N. Tumor Immunity
and Immunotherapy for HPV-Related Cancers. Cancer Discov.
2021;11(8):1896-1912. doi: 10.1158/2159-8290.CD-20-1760
- Guidry JT, Scott RS. The interaction between human papillomavirus and
other viruses. Virus Res. 2017;231:139-147. doi:
10.1016/j.virusres.2016.11.002
- Vazifehdoost M, Eskandari F, Sohrabi A. Trends in cocirculation of
oncogenic HPV genotypes in single and multiple infections among
the unvaccinated community. J Med Virol. 2022;94(7):3376-3385. doi:
10.1002/jmv.27706
- Rositch AF, Gravitt PE, Tobian AA, Newell K, Quinn TC, Serwadda D, et
al. Frequent detection of HPV before and after initiation of
antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.
PLoS One. 2013;8(1):e55383. doi: 10.1371/journal.pone.0055383
- Massad L, Keller M, Xie X, Minkoff H, Palefsky J, DʼSouza G, et al.
Multitype Infections With Human Papillomavirus: Impact of Human
Immunodeficiency Virus Coinfection. Sex Transm Dis.
2016a;43(10):637-41. doi: 10.1097/OLQ.0000000000000501
- Massad LS, Xie X, Burk RD, D’Souza G, Darragh TM, Minkoff H, et al.
Association of cervical precancer with human papillomavirus types
other than 16 among HIV co-infected women. Am J Obstet Gynecol.
2016b;214(3):354.e1-6. doi: 10.1016/j.ajog.2015.09.086
- Bacik LC, Chung C. Human papillomavirus-associated cutaneous disease
burden in human immunodeficiency virus (HIV)-positive patients: the
role of human papillomavirus vaccination and a review of the
literature. Int J Dermatol. 2018;57(6):627-634. doi: 10.1111/ijd.13819
- Ferré VM, Gbeasor-Komlanvi FA, Collin G, Dagnra AC, Le Hingrat Q,
Jaquet A, et al. Prevalence of Human Papillomavirus, Human
Immunodeficiency Virus, and Other Sexually Transmitted Infections
Among Men Who Have Sex With Men in Togo: A National Cross-sectional
Survey. Clin Infect Dis. 2019;69(6):1019-1026. doi:
10.1093/cid/ciy1012
- Pérez-González A, Cachay E, Ocampo A, Poveda E. Update on the
Epidemiological Features and Clinical Implications of Human
Papillomavirus Infection (HPV) and Human Immunodeficiency Virus (HIV)
Coinfection. Microorganisms. 2022;10(5):1047. doi:
10.3390/microorganisms10051047
- Mulherkar TH, Gómez DJ, Sandel G, Jain P. Co-Infection and Cancer:
Host-Pathogen Interaction between Dendritic Cells and HIV-1, HTLV-1,
and Other Oncogenic Viruses. Viruses. 2022;14(9):2037. doi:
10.3390/v14092037.
- Amirian ES, Adler-Storthz K, Scheurer ME. Associations between human
herpesvirus-6, human papillomavirus and cervical cancer. Cancer Lett.
2013;336(1):18-23. doi: 10.1016/j.canlet.2013.04.023
- Moharreri M, Sohrabi A. Characteristics of HSV-2, M. genitalium and C.
trachomatis in HPV Genotypes Associated with Cervical Intraepithelial
Neoplasia and Genital Infections. Infect Disord Drug Targets.
2021;21(1):112-118. doi: 10.2174/1871526520666191231142317
- Soares CC, Georg I, Lampe E, Lewis L, Morgado MG, Nicol AF, et al.
HIV-1, HBV, HCV, HTLV, HPV-16/18, and Treponema pallidum infections in
a sample of Brazilian men who have sex with men. PLoS One.
2014;9(8):e102676. doi: 10.1371/journal.pone.0102676
- Shi Y, Peng SL, Yang LF, Chen X, Tao YG, Cao Y. Co-infection of
Epstein-Barr virus and human papillomavirus in human tumorigenesis.
Chin J Cancer. 2016;35:16. doi: 10.1186/s40880-016-0079-1
- Vazquez-Guillen JM, Palacios-Saucedo GC, Rivera-Morales LG,
Alonzo-Morado MV, Burciaga-Bernal SB, Montufar-Martinez M, et al.
Infection and coinfection by human papillomavirus, Epstein-Barr virus
and Merkel cell polyomavirus in patients with squamous cell carcinoma
of the larynx: a retrospective study. PeerJ. 2018;6:e5834. doi:
10.7717/peerj.5834
- de Lima MAP, Teodoro IPP, da Silva CGL, Lima MVA. Role of Epstein-Barr
Virus and Human Papillomavirus Coinfection in Oral and Anogenital
Carcinogenesis: Potential Tumorigenic Pathways. Crit Rev Oncog.
2019;24(4):403-413. doi: 10.1615/CritRevOncog.2020033071
- Blanco R, Carrillo-Beltrán D, Osorio JC, Calaf GM, Aguayo F. Role of
Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical
Cancer: Epidemiology, Mechanisms and Perspectives. Pathogens.
2020;9(9):685. doi: 10.3390/pathogens9090685
- Harabajsa S, Šefčić H, Klasić M, Milavić M, Židovec Lepej S, Grgić I,
et al. Infection with human cytomegalovirus, Epstein-Barr virus, and
high-risk types 16 and 18 of human papillomavirus in EGFR-mutated lung
adenocarcinoma. Croat Med J. 2023;64(2):84-92. doi:
10.3325/cmj.2023.64.84
- Zhu H, Shen Z, Luo H, Zhang W, Zhu X. Chlamydia Trachomatis
Infection-Associated Risk of Cervical Cancer: A Meta-Analysis.
Medicine (Baltimore). 2016;95(13):e3077. doi:
10.1097/MD.0000000000003077
- Kumari S, Bhor VM. A literature review on correlation between HPV
coinfection with C. trachomatis and cervical neoplasia - coinfection
mediated cellular transformation. Microb Pathog. 2022;168:105587. doi:
10.1016/j.micpath.2022.105587
- Dong B, Huang Y, Cai H, Chen Y, Li Y, Zou H, et al. Prevotella as the
hub of the cervicovaginal microbiota affects the occurrence of
persistent human papillomavirus infection and cervical lesions in
women of childbearing age via host NF-κB/C-myc. J Med Virol.
2022;94(11):5519-5534. doi: 10.1002/jmv.28001
- Santella B, Schettino MT, Franci G, De Franciscis P, Colacurci N,
Schiattarella A, Galdiero M. Microbiota and HPV: The role of viral
infection on vaginal microbiota. J Med Virol. 2022;94(9):4478-4484.
doi: 10.1002/jmv.27837
- Rosário A, Sousa A, Varandas T, Marinho-Dias J, Medeiros R, Martins G,
et al. Impact of cervicovaginal microbiome on the risk of cervical
abnormalities development. J Med Virol. 2023;95(5):e28762. doi:
10.1002/jmv.28762
- Taku O, Brink A, Meiring TL, Phohlo K, Businge CB, Mbulawa ZZA,
Williamson AL. Detection of sexually transmitted pathogens and
co-infection with human papillomavirus in women residing in rural
Eastern Cape, South Africa. PeerJ. 2021;9:e10793. doi:
10.7717/peerj.10793
- Hammer A, Gravitt PE, Adcock R, Patterson N, Cuzick J, Wheeler CM; New
Mexico HPV Pap Registry Steering Committee. Burden of Mycoplasma
genitalium and Bacterial Coinfections in a Population-Based Sample in
New Mexico. Sex Transm Dis. 2021;48(12):e186-e189. doi:
10.1097/OLQ.0000000000001472
- Verteramo R, Pierangeli A, Mancini E, Calzolari E, Bucci M, Osborn J,
et al. Human Papillomaviruses and genital co-infections in
gynaecological outpatients. BMC Infect Dis. 2009;9:16. doi:
10.1186/1471-2334-9-16
- Gholizadeh O, Yekanipour Z, Kivi S, Farahbod F, Aqayinejad M,
Tasoujizade Y, Yasamineh S, et al. Review of the evidence of the
effects of human papillomavirus infection and Gardnerella vaginalis,
and their co-infection on infertility. Microb Pathog. 2023;175:105980.
doi: 10.1016/j.micpath.2023.105980
- da Silva BEB, Santos VS, Santos IER, Araújo ED, Alves MV, Silva LADS,
et al. Prevalence and genotype distribution of human papillomavirus in
women living with HIV/AIDS in an area of Northeast Brazil. J Med
Virol. 2020 Apr 24. doi: 10.1002/jmv.25935
- Paula Almeida Cunha A, Kassandra Pereira Belfort I, Pedro Belfort
Mendes F, Rodrigues Bastos Dos Santos G, Henrique de Lima Costa L, de
Matos Monteiro P, et al. Human papillomavirus and Its Association with
Other Sexually Transmitted Coinfection among Sexually Active Women
from the Northeast of Brazil. Interdiscip Perspect Infect Dis.
2020;2020:8838317. doi: 10.1155/2020/8838317
- Marur S, D’Souza G, Westra WH, Forastiere AA. HPV-associated head and
neck cancer: a virus-related cancer epidemic. Lancet Oncol.
2010;11(8):781-9. doi: 10.1016/S1470-2045(10)70017-6
- Marur S, Forastiere AA. Head and Neck Squamous Cell Carcinoma: Update
on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc.
2016;91(3):386-96. doi: 10.1016/j.mayocp.2015.12.017
- Spence T, Bruce J, Yip KW, Liu FF. HPV Associated Head and Neck
Cancer. Cancers (Basel). 2016;8(8):75. doi: 10.3390/cancers8080075.
- Berman TA, Schiller JT. Human papillomavirus in cervical cancer and
oropharyngeal cancer: One cause, two diseases. Cancer.
2017;123(12):2219-2229. doi: 10.1002/cncr.30588
- Tanaka TI, Alawi F. Human Papillomavirus and Oropharyngeal Cancer.
Dent Clin North Am. 2018;62(1):111-120. doi:
10.1016/j.cden.2017.08.008
- Sabatini ME, Chiocca S. Human papillomavirus as a driver of head and
neck cancers. Br J Cancer. 2020;122(3):306-314. doi:
10.1038/s41416-019-0602-7
- Tumban E. A Current Update on Human Papillomavirus-Associated Head and
Neck Cancers. Viruses. 2019;11(10):922. doi: 10.3390/v11100922
- Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR.
Head and neck squamous cell carcinoma. Nat Rev Dis Primers.
2020;6(1):92. doi: 10.1038/s41572-020-00224-3. Erratum in: Nat Rev Dis
Primers. 2023 Jan 19;9(1):4.
- Mody MD, Rocco JW, Yom SS, Haddad RI, Saba NF. Head and neck cancer.
Lancet. 2021;398(10318):2289-2299. doi: 10.1016/S0140-6736(21)01550-6
- Nogues JC, Fassas S, Mulcahy C, Zapanta PE. Human
Papillomavirus-Associated Head and Neck Cancer. J Am Board Fam Med.
2021;34(4):832-837. doi: 10.3122/jabfm.2021.04.200588
- Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal
cancer: epidemiology, molecular biology and clinical management. Nat
Rev Clin Oncol. 2022;19(5):306-327. doi: 10.1038/s41571-022-00603-7
- Raj S, Kesari KK, Kumar A, Rathi B, Sharma A, Gupta PK, et al.
Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head
and neck cancer. Mol Cancer. 2022 ;21(1):31. doi:
10.1186/s12943-022-01503-1
- Trivedi S, Sun L, Aggarwal C. Immunotherapy for Head and Neck Cancer.
Hematol Oncol Clin North Am. 2021;35(5):1021-1037. doi:
10.1016/j.hoc.2021.05.010
- Palefsky JM. Human papillomavirus-associated anal and cervical cancers
in HIV-infected individuals: incidence and prevention in the
antiretroviral therapy era. Curr Opin HIV AIDS. 2017;12(1):26-30. doi:
10.1097/COH.0000000000000336
- Wang CJ, Sparano J, Palefsky JM. Human Immunodeficiency Virus/AIDS,
Human Papillomavirus, and Anal Cancer. Surg Oncol Clin N Am.
2017;26(1):17-31. doi: 10.1016/j.soc.2016.07.010
- Otter S, Whitaker S, Chatterjee J, Stewart A. The Human Papillomavirus
as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers. Clin
Oncol (R Coll Radiol). 2019;31(2):81-90. doi:
10.1016/j.clon.2018.10.004
- Valvo F, Ciurlia E, Avuzzi B, Doci R, Ducreux M, Roelofsen F, et al.
Cancer of the anal region. Crit Rev Oncol Hematol. 2019;135:115-127.
doi: 10.1016/j.critrevonc.2018.12.007
- Wang CJ, Palefsky JM. HPV-Associated Anal Cancer in the HIV/AIDS
Patient. Cancer Treat Res. 2019;177:183-209. doi:
10.1007/978-3-030-03502-0_7
- Albuquerque A, Nathan M, Cappello C, Dinis-Ribeiro M. Anal cancer and
precancerous lesions: a call for improvement. Lancet Gastroenterol
Hepatol. 2021;6(4):327-334. doi: 10.1016/S2468-1253(20)30304-6
- Vegunta S, Shah AA, Whited MH, Long ME. Screening Women for Anal
Cancers: Guidance for Health Care Professionals. Am J Gastroenterol.
2021;116(3):509-516. doi: 10.14309/ajg.0000000000001186
- Eng C, Ciombor KK, Cho M, Dorth JA, Rajdev LN, Horowitz DP, et al.
Anal Cancer: Emerging Standards in a Rare Disease. J Clin Oncol.
2022;40(24):2774-2788. doi: 10.1200/JCO.21.02566